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Abstract
Background: Mast cells(MC) are cells of the immune cells which can secrete a variety of molecules. 
Many studies suggest that mast cells may either promote tumour growth in some types of cancer 
or may act in an opposite manner in other tumour types. Aim: To evaluate the association of mast 
cells in the different grades of Oral Squamous Cell Carcinoma(OSCC). Material and methods: 
Fifteen diagnosed cases each of well, moderate and poorly differentiated OSCC were identified 
from the institutional archival material. Two slides each were made of 5 µm thickness and stained 
with Hematoxylin and eosin and 1% Toluidine blue stain. Each section was evaluated for mast 
cells in peritumoural, intratumoural locations and at the invasive front of the tumour. The results 
obtained were subjected to statistical evaluation by an SPSS version 19 using Chi square test, 
Anova and Post hoc Tuckey tests. Results: An inverse relation was observed between MC count 
with grade of the tumour with maximum MC located in the peritumoural area followed by the 
invasive front and the least in the intra tumoural areas. Conclusion: The results of the present 
study suggest that a decrease in MC count is associated with an advanced histologic grade of 
OSCC and hence a poorer prognosis, thus favouring the protective role of mast cells in OSCC.
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Introduction
Following the discovery of Mast cells (Mastzellen) by Paul 
Ehrlich many advances have improved our understanding of 
these cells and their fascinating biology. Mast cells are commonly 
seen in various tumours and have been attributed alternatively 
with tumour promotion and tumour rejection. Animal and 
pathologic studies suggest that mast cells may promote tumor 
growth in some cancer types but may act in an opposite manner 
in others. In several mouse models a critical role of mast 
cells for tumor promotion was demonstrated. They directly 
influence tumour proliferation and invasion and indirectly by 
organizing the tumour microenvironment and modulating 
immune responses. Various studies in potentially malignant and 
malignant oral disorders have shown the association of mast 
cells. However, no studies show their association in the various 
parts of the progressing front of the tumour. Hence the study 
was planned with the intention of evaluating the role of mast 
cells in progression of OSCC.
Materials and Methods
A retrospective histological study was planned and after due 
approval of the institutional ethics committee, a sample of 
45 histologically diagnosed cases was selected. The tissues 
blocks were prepared from tissue fixed in 10% neutral buffered 
formalin, fixed overnight at room temperature were obtained 
from the department archives. Fifteen cases each of well, 
moderate and poorly differentiated OSCC were identified from 
the archival material of the Department of Oral Pathology and 
Microbiology, SDS, KIMSDU. Two slides each were made of 
5 µm thickness from the excisional biopsy specimen of these 
cases. One slide was stained with Hematoxylin and Eosin, 
which was used to evaluate and confirm the grade of the tumour 
and to exclude cases with sparse connective tissue. The second 
slide was stained with1% Toluidine blue for mast cells. 
Three areas were decided for carrying out the mast cell count; 
1) peritumoural-areas more than 2 high power fields away from 
the invasive front, 2) intratumoural-areas with the tumour mass 
and 3) invasive front of the tumour. Each section was scanned 
and 3 high power fields at peritumoural, intratumoural locations 
and at the invasive front of the tumour were identified and used 
for data collection. A single observer made these observation 
3 different times and the average of the score was used for the 
study. The number of mast cell were counted in each of these 
fields taking care not to overlap the areas and recount mast cells. 
The results obtained were subjected to statistical evaluation by 
an SPSS version 19 using Chi square test, Anova and Post hoc 
Tuckey tests. P value of less than 0.05 was considered to be 
statistically significant.
Results 
The data when subjected to Chi square test revealed that mast 
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cells were most numerous in well differentiated OSCC followed 
by moderate and poor differentiation. In all the three grades the 
mean and standard deviation as described in the figure was 
maximum for peritumoural area followed by invasive front and 
the least for intratumoural area [Table 1].
The data was subjected to Anova for comparison of MC count 
in peritumoural area, invasive front and intratumoural area 
between well, moderate and poorly differentiated OSCC. The 
values for standard deviation for Peritumoural area was ±6.33, 
invasive front ±4.05 and intratumoural ±2.81 [Table 2]. A 
statically significant difference was elicited in the peritumoural 
and invasive front areas in comparison to intratumoural areas in 
all the three grades of OSCC.
When well differentiated OSCC was compared with moderate 
and poorly differentiated OSCC using Post hoc Tuckey, a 
statistically significant difference was seen between well and 
poorly differentiated OSCC in peritumoural and invasive front 
areas [Tables 3, 4 and 5].
Discussion
It is well established that cancer is a progressive disease, 
occurring in a series of well-defined steps. There is a reciprocal 
signaling interaction between cancer cells and stromal cells 
within the tumour microenvironment. Initiated cells require 
alterations rendering them self-sufficient for growth, insensitive 
to growth-inhibitory signals, resistant to programs of terminal 
differentiation, senescence, or apoptosis, as well as endowing 
them with unlimited self-renewal capacity, the ability to 
orchestrate and direct sustained angiogenesis, and the ability to 
invade and thrive in ectopic tissue environments.[1]
The association between inflammation and cancer was 
discovered by Rudolf Virchow, who first described the presence 
of a leukocyte infiltrate in tumour tissues.[2]
In neo-plastic tissues, inflammatory cells act in concert with 
tumour cells, stromal cells and endothelial cells to create a 
microenvironment that is critical for the survival, development 
and dissemination of the neoplastic mass.[1]
Mast cells(MC) are bone marrow-derived tissue-homing 
leukocytes, which were first described by Paul Ehrlich. They 
appear as highly versatile cells playing an important role in 
large spectrum of biological settings, including inflammation, 
angiogenesis, tissue repair, tissue remodeling and cancer.[3]
They are arguably the most productive chemical factory in the 
body and influence other cells through both soluble mediators 
and cell-to-cell interaction. MC are commonly seen in various 
tumours and have been attributed alternatively with tumour 
rejection or tumour promotion.[4]
Mast cells attracted in the tumour microenvironment by stem 
cell factor (SCF) secreted by tumour cells produce several 
angiogenic factors as well as matrix metalloproteinases (MMPs), 
which promote tumour vascularization and invasiveness, 
respectively.[3]
Mast cells accumulate in the stroma surrounding certain 
tumours, especially mammary adenocarcinoma, and molecules 
they secrete could benefit the tumour. These include heparin, 
interleukin-8 (IL-8) and vascular endothelial cell growth factor 
Table 1: Comparison of Mast cell count in different grades and 
different tumour locations






differentiated 9.3 (±4.2) 13.8 (±6.3) 5.2 (±2.5) 0.99
Moderately 




(±2.94) 3.73 (±2.9) 2.2 (±2.4) 0.79
Chi square test
P value of <0.05 is considered statistically significant
Table 3: Posthoc Tuckey Peritumoural area
Mean Difference Standard Error Significance 
2 3.13333 ±1.78234 < 0.01 
3 9.86667* ±1.78234 < 0.01 
1 -3.13333 ±1.78234 < 0.01 
3 6.73333* ±1.78234 < 0.01
1 -9.86667* ±1.78234 < 0.01
2 -6.73333* ±1.78234 < 0.01
Post hoc tuckey test 
P value of <0.05 is considered  statistically significant




Difference Standard Error Significance 
1 
2 2.26667 ±1.21106 < 0.01
3 5.86667
*
 ±1.21106 < 0.01 
2 
1 -2.26667 ±1.21106 < 0.01
3 3.60000
*




 ±1.21106 < 0.01
2 -3.60000
*
 ±1.21106 < 0.01 
Post hoc tuckey test 
P value of <0.05 is considered  statistically significant
Table 2 Results of Anova
Comparison between 
well, moderate and poorly 
differentiated OSCC 
 Mean Standard   deviation Significance 
Peritumoural 9.4667 ±6.33030 < 0.01
Invasive front 6.6222 ±4.05804 < 0.01
Intratumoural 3.9333 ±2.81554 < 0.01
ANOVA test 
P value of <0.05 is considered  statistically significant




Difference Standard Error Significance 
1 
2 0.80000 ±0.93673 < 0.01 
3 3.00000* ±0.93673 < 0.01 
2 
1 -0.80000 ±0.93673 < 0.01 
3 2.20000 ±0.93673 < 0.01
3 
1 -3.00000* ±0.93673 < 0.01
2 -2.20000 ±0.93673 < 0.01
Post hoc tuckey test 
P value of <0.05 is considered  statistically significant
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We also observed that when we did see mast cells in intratumoural 
areas or invasive fronts they were in close proximity to the 
neoplastic cells. Another observed finding was that apart from 
the established perivascular sites increased MC counts were 
also observed in the salivary gland tissue seen in proximity to 
the tumour. Further studies may be carried out to ascertain if 
there is any association between the two.
The limitations of the study were a small sample size and a 
single observer due to the limited availability of personnel and 
resources. Though there are studies on mast cells and squamous 
cell carcinoma no previous data is available on the presence of 
mast cell in various parts of the tumour and their association in 
the different grades of oral squamous cell carcinoma which is 
the strength of the study. Within the limitations of the study the 
observation obtained from the current study and more detailed 
and molecular studies will help us understand the role and 
behaviour of mast cell in the intra tumoural area, invasive front 
and peritumoural areas of oral squamous cell carcinoma and help 
us draw more conclusive data on the exact mechanisms, which 
in turn will aid in developing therapeutic applications using 
mast cells in the treatment of oral squamous cell carcinoma.
Conclusion
In our study, we found an association between the histological 
(VEGF), which induce neovascularization, histamine, which 
is an immunosuppressant, mitogenic factors, such as platelet-
derived growth factor (PDGF), nerve GF (NGF), stem-cell factor 
(SCF), and proteases, which disrupt the surrounding matrix 
and facilitate metastases. By contrast, mast-cell mediators 
detrimental to the tumour include cytokines, such as IL-1, IL-4, 
IL-6 and tumour necrosis factor-α (TNF-α), which can induce 
apoptosis of tumour cells, tryptase, which stimulates protease-
activated receptors and induces inflammation, and chondroitin 
sulfate, which could act as a decoy and inhibit metastases.[5]
Many studies have demonstrated tumour growth induction 
secondary to mast cell activation. Diverse mechanisms such as 
the release of pro-angiogenic inducers and activation of CD30 
by mast cells have been observed.[6]
Coussens et al. reported that mast cells, “infiltrate hyperplasia, 
dysplasias, and invasive fronts of carcinomas,” and then release 
the mast cell-specific proteases chymase and tryptase-the 
former acting as a mitogen and the latter being angiogenic to 
skin fibroblasts.[7]
Ribatti et al. have suggested that an increased MC count is 
associated with progression from common nevi to malignant 
melanoma. The higher the mast cell counts in the tissue, the 
deeper the penetration into the dermis and the more likely the 
tumour is to undergo metastasis.[8]
Increased mast cells are also associated with squamous cell 
carcinomas. A correlation between mast cell numbers and poor 
outcome was reported in a paper by Iamaroon et al. on oral 
squamous cell carcinoma. Costa et al. paper reported a high 
concentration of tryptase produced by mast cells in squamous 
cell carcinoma of the lip.[9,10]
However, in our study we found a decrease in the number of 
mast cell as the grade of tumour progressed from well to poorly 
differentiated OSCC suggesting a protective role of mast cells 
in OSCC as against the earlier mentioned studies. The results 
of our study were in favour with Debta et al. who in their study 
on mast cells and eosinophils concluded that these cells are 
favourable indicators in OSCC.[11]
The other points that were also observed during the present 
study was a decrease in the number of MCs in the invasive 
front and intratumoural area in comparison to the peritumoural 
areas of OSCC [Figures 1a, 1b and 1c]. Reasons for this may 
be understood from histochemical and molecular studies on 
the mechanisms that determine the pathway that mast cells will 
eventually select in bringing about the final outcome.
In a study on 55 cases of infiltrating ductal carcinomas, the 
results were similar to our study with higher mast cell count 
in lower grade tumours, suggesting a protective role of mast 
cells in breast cancers. They also found that the MC counts 
were more in peritumoural and intratumoural areas of well 
differentiated tumours which was also found in the present 
study. The reason for increase in MC numbers on peritumoural 
areas was suggested due to possible migration of mast cells by 
tumour derived chemoattractents.
Figure 1a: Mast cells in peritumoural area.
Figure 1b: Mast cells in the invasive front area.
Figure 1c: Mast cells in intratumoural area.
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grade of OSCC with the MC count. The decrease in the MC 
count from well to poorly differentiated OSCC was found to be 
statistically significant. The results of the present study suggest 
that a decrease in MC count is associated with an advanced 
histologic grade of OSCC and hence a poorer prognosis, thus 
favouring the protective role of mast cells in OSCC.
The famous author Robert Frost may not have dreamt that 
his quote “The woods are lovely, dark and deep. But I have 
promises to keep and miles to go before I sleep” could apply 
so aptly to the research on the Jeckyl and Hyde of tumour 
microenvironment. The type of mast cells, the products these 
cells secret, their migration and degranulation and other factors 
that eventually decide the behaviour of MC need to be studied 
for precisely targeting treatment modalities that utilize mast 
cells and for establishing reasons as to why these cells function 
differently at different situations We hope that future studies 
open new dimensions and shed new light towards a better 
understating and behaviour of this Paul Ehlrich’s legend, that 
stills lives on.
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